David Jefferys
Impact in
-
- Quality and Safety in Healthcare
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Pharmaceutical Economics and Policy 3
-
- Cardiac, Anesthesia and Surgical Outcomes 2
- Co-authors
- Donald S. Baim (3 shared papers)Richard E. Kuntz (3 shared papers)Aaron V. Kaplan (3 shared papers)Michael Simons (3 shared papers)Martin B. Leon (3 shared papers)Thomas J. Fogarty (3 shared papers)John J. Smith (1 shared paper)M. D. Rawlins (1 shared paper)
- Journals
- Drug Information Journal (4 papers)British Journal of Clinical Pharmacology (2 papers)Circulation (2 papers)European Journal of Clinical Pharmacology (1 paper)Trends in Pharmacological Sciences (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
David Jefferys
15 papers receiving 276 citations
Peers
Comparison fields: 5 of 100
- Medical Laboratory Technology 18
- Toxicology 24
- Pharmacology 38
- Complementary and alternative medicine 25
- Economics and Econometrics 90
Countries citing papers authored by David Jefferys
This map shows the geographic impact of David Jefferys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Jefferys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Jefferys more than expected).
Fields of papers citing papers by David Jefferys
This network shows the impact of papers produced by David Jefferys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Jefferys. The network helps show where David Jefferys may publish in the future.
Co-authors
The 16 scholars most cited alongside David Jefferys, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 126 | |
| 2 | 1998 | 54 | |
| 3 | 2001 | 39 | |
| 4 | 1983 | 35 | |
| 5 | 2004 | 32 | |
| 6 | 1995 | 8 | |
| 7 | 1995 | 4 | |
| 8 | EMEA (European Medicines Evaluation Agency) and the new pharmaceutical procedures for Europe. | 1994 | 3 |
| 9 | 1993 | 2 | |
| 10 | 2003 | 2 | |
| 11 | 1992 | 2 | |
| 12 | 2001 | 1 | |
| 13 | A Call for a More Integrated and Comprehensive Approach | 2004 | 1 |
| 14 | Workshop on devices: regional issues surrounding regulatory requirements for nebulizers | 2009 | 1 |
| 15 | 1996 | 1 | |
| 16 | 1997 | 1 | |
| 17 | 2006 | 0 |
About David Jefferys
David Jefferys is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine, Physiology, Surgery and Strategy and Management, having authored 17 papers that have together received 312 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Biomedical Ethics and Regulation (3 papers), Pharmaceutical Economics and Policy (3 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers), Coronary Interventions and Diagnostics (2 papers), Intellectual Property and Patents (1 paper), Pharmacogenetics and Drug Metabolism (1 paper) and Agricultural safety and regulations (1 paper). The work is most often cited by research in Medical Laboratory Technology (18 citations), Toxicology (24 citations), Pharmacology (38 citations), Complementary and alternative medicine (25 citations) and Economics and Econometrics (90 citations). David Jefferys has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Donald S. Baim, Richard E. Kuntz, Aaron V. Kaplan, Michael Simons, Martin B. Leon, Thomas J. Fogarty, John J. Smith, M. D. Rawlins, John A. Lewis and Karen H. Jones. Their work appears in journals such as Drug Information Journal, British Journal of Clinical Pharmacology, Circulation, European Journal of Clinical Pharmacology and Trends in Pharmacological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.